Digestive Health Supplements Market

Expanding aging population with higher digestive care needs

Demographic aging represents a key macro-driver in the digestive health supplement sector, with profound implications for market growth, product development, and revenue potential. According to the UN World Population Prospects 2024, by 2025 the global population aged 65 and above will surpass 761 million accounting for 16% of the total population and is projected to grow at 2.3% annually, nearly triple the rate of the overall population.

This demographic shift is particularly pronounced in developed markets, with Europe leading at 20.8% of its population over 65, North America at 17.6%, and the Asia-Pacific region reaching 549 million older adults by 2025.

• Data from the WHO Global Health Observatory underscores a clear link between aging and digestive morbidity, with adults over 65 experiencing 3.2 times higher prevalence of chronic gastritis, 2.7 times higher incidence of GERD, and significantly elevated rates of diverticular disease, constipation, and medication-associated dysbiosis relative to younger cohorts.

Rising demand for personalized and targeted digestive nutrition

The digestive health supplement market is experiencing a rapid shift toward personalized and targeted nutrition, driven by growing consumer interest in solutions tailored to individual digestive profiles, lifestyles, and wellness goals. Advances in microbiome science, wearable technology, and direct-to-consumer testing services have enabled consumers to understand their unique gut health needs, fueling demand for supplements designed to address specific conditions such as bloating, irregularity, or immune support. Brands are responding by offering customizable probiotic blends, targeted enzyme formulations, and condition-specific prebiotics, often supported by digital tools that provide personalized recommendations.

• Viome Life Sciences' Full Body Intelligence™ Test, launched April 2025, analyzes stool, saliv a, and blood samples using RNA sequencing to assess 100+ million biomarkers, generating personalized nutrition and supplement guidance for over 25 chronic conditions including IBS and metabolic disease. This represents a paradigm shift from generic probiotics to precision interventions based on real-time gene expression data.

Digestive health disorders are rising globally and represent a growing burden on healthcare systems, creating strong demand for effective supplement solutions. WHO data shows digestive diseases as a major contributor to disability-adjusted life years, while recent meta-analysis (2025) estimates that functional gastrointestinal disorders affect around 40% of the global population, with IBS impacting 14.1% of adults.
 

• This trend is clearly reflected in the UK, where 35% of adults over 22 million people now report chronic digestive issues, up from 25% a decade ago; IBS affects approximately one in five adults, and IBD diagnoses have surpassed 550,000, with faster growth among younger populations. Infectious gastrointestinal conditions are also increasing, with UK Campylobacter and Salmonella cases rising by over 17% year on year and continuing to trend upward in 2025.

 
Similar patterns are seen in the US, where more than 100,000 individuals under 20 are living with IBD, representing significant growth since 2009. Inflammatory bowel disease (IBD) diagnoses are also increasing sharply, particularly among younger demographics, while infectious gastrointestinal conditions such as Campylobacter and Salmonella continue to show double digit year over year growth. This escalating disease burden places significant strain on healthcare systems, where average wait times for gastroenterology consultations often exceed 18–24 weeks.
 
As a result, consumers are increasingly turning to evidence-based supplements—including probiotics, fiber blends, digestive enzymes, and functional foods as accessible, preventive, and adjunctive solutions for symptom management. With digestive disorders accounting for 12% of primary care visits, 30% of gastroenterology outpatient consultations, and one in three people experiencing digestive discomfort at any given time.

The increasing recognition of the gut’s central role in overall health is a key driver of the digestive health supplement market. Consumers are becoming more aware of the connection between gut health and immunity, energy levels, mood regulation, and chronic disease prevention. This heightened awareness—amplified by scientific research, wellness influencers, and digital health platforms is shifting consumer behavior from reactive treatment to proactive prevention.
 

• As a result, demand is rising for probiotics, prebiotics, fiber blends, and clean-label functional foods that support digestive balance and holistic well-being. Health-conscious millennials and Gen Z, in particular, are fueling growth by prioritizing natural, evidence-based solutions that align with broader wellness and lifestyle trends.

North America: US forefront amid wellness culture

North America leads in the Digestive Health Supplements Market size, accounting for over 41.19% of the global revenue in 2024. Driven by high GI disorder prevalence, sedentary lifestyles, and strong nutraceutical presence (e.g., Bayer AG, Pfizer). Probiotics lead; US forefront amid wellness culture, with innovations in plant-based formulas.

• CDC reports that 60–70 million Americans suffer from digestive diseases annually, creating sustained demand for supplements supporting gut health. WHO highlights rising chronic disease burden linked with lifestyle factors, encouraging preventive probiotic and enzyme supplementation adoption across healthcare systems in the region.

Europe: forefront amid wellness culture

Europe Digestive Health Supplements Market size was valued at USD 3852.06 Million in 2024, making it the second-largest regional market with a 30% share. Aging population (20% over 65 by 2030) and digestive disorders (IBS: 10-20%; pancreatitis high in Finland/Poland) propel demand. Western diets, stress amplify dyspepsia, IBD. EFSA-compliant claims foster trust; prescribed supplements grow fastest (doctors recommend 40% cases). Online retail surges at 10%+ CAGR, with platforms like Boots.com, Amazon EU. Natural ingredients boom: Mediterranean herbs (fennel, anise), fermented foods (kefir). Sustainability mandates (EU Green Deal) push eco-packaging, organic certifications.

• WHO European region data highlights increasing burden of gastrointestinal disorders, especially among aging populations exceeding 20% over 65 in several countries. ECDC supports growing focus on preventive healthcare strategies, boosting adoption of clinically validated digestive supplements across pharmacies and retail channels.

Asia Pacific: Fastest Growing medical aesthetics

APAC, largest region, grows from USD 3.22B in 2026 at 6.91-11.9% CAGR to USD 19.64B by 2034. Urbanization (60% by 2030), rising incomes (middle-class 5B), GI issues from spicy/processed foods drive it. India/China/Japan lead. Ayurveda/TCM fusion (turmeric probiotics); e-commerce (Tmall, Flipkart, 7.88% CAGR). Preventive wellness post-COVID; probiotics for immunity. China: 7.9% CAGR, cross-border e-com (daily gut routines).

India: 8.11% CAGR, FSSAI-backed, Nestlé-Dr. Reddy's JV. Japan (26.92% share, yakult dominance). Pharmacies (34%), online exploding. Prebiotics fastest (8.04-8.34%). India: Capsules (powders for affordability). China: Liquids/beverages. ASEAN (Indonesia): Herbal blends. Japan: Spore probiotics resilient.

South America: Growing amid wellness culture

The regulatory framework for the body fat reduction market in South America is anchored in a growing emphasis on patient safety, clinical quality, and professional accountability, though the level of oversight varies significantly from country to country. Accreditation serves as a baseline for safety and quality, setting minimum standards that clinics and hospitals must meet to operate legally, particularly in procedures like liposuction and other fat reduction treatments.

Colombia leads the region in regulatory rigor, with its Ministry of Health and the Colombian Society of Plastic Surgery (SCCP) working in tandem to enforce strict rules around surgeon qualifications, hygiene protocols, and patient care standards. Clinics in Colombia must demonstrate ongoing compliance, including continuous professional development and operational safety, or risk closure. The SCCP plays a critical role by ensuring that only board-certified plastic surgeons perform invasive procedures such as liposuction.

Middle East & Africa: Emerging Pharmacy chains

MEA at USD 435M-480M in 2025-26, reaches USD 951M by 2033 at 10.2-10.3% CAGR—fastest globally. Youthful demographics (60% under 30), Vision 2030 (KSA), urbanization fuel shift to preventives. GI from fast food/desert diets. Pharmacy chains expansion (Boots UAE), halal-certified probiotics. Herbal tonics (dates, camel milk enzymes) blend with Western. KSA/UAE/South Africa 70% share; Africa via mobile health apps. Digestive enzymes key (lactose intolerance 70% Middle East). Probiotics 45%. Distribution: Hypermarkets (Nahdi, Dis-Chem), online 15% CAGR. Forms: Gummies for youth.

Many global, regional, and local vendors characterize the Digestive Health Supplements Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.
 
The major players in the market Include, DSM Firmenich, Bayer AG, Herbalife International, Ltd., Nestle, Danone S.A., Pfizer, Inc. strategic market developments and decisions to improve operational effectiveness.
 
Key Companies in the Digestive Health Supplements Market Include
 
DSM Firmenich, Bayer AG, Herbalife International, Ltd., Nestle, Danone S.A., Pfizer, Inc.
 
Recent News:
 
August 2025: Bayer Consumer Health introduced Iberogast, a plant-based digestive relief product, to the United States. Formulated with a clinically proven, proprietary six-herb blend, Iberogast harnessed the power of nature to provide dual-action relief for individuals experiencing occasional digestive symptoms by helping relieve stomach upsets and restore digestive function.
 
October 2025: The Culturelle brand of probiotics released adult and kids probiotic gummies containing Bacillus subtilis DE111, a scientifically studied probiotic strain shown to support a healthy digestive system. A clinical trial demonstrated that Bacillus subtilis DE111 significantly improved gastrointestinal discomfort and increased the frequency of normal stools in individuals experiencing occasional constipation and/or diarrhea.
 
September 2025: Herbalife Nutrition introduced Active Fiber Complex Select, a tropical twist–flavored dietary fiber supplement, across the U.S., Puerto Rico, and Canada to strengthen its digestive health portfolio. The product delivers 6 grams of fiber per serving with a balanced mix of soluble and insoluble fiber to support digestion, regular bowel function, and gut microbiota growth. It is gluten-free, low glycemic, vegetarian and kosher certified, non-GMO, free from artificial flavors and sweeteners, and suitable for diabetics. The launch addresses the widespread fiber intake deficiency among North American consumers and complements Herbalife’s existing digestive health offerings, reinforcing the company’s focus on science-backed nutrition solutions.